|
Generic:
|
|
Tranexamic acid
|
| |
|
Therapeutic Class:
|
|
Antifibrinolytic
|
| |
|
Composition:
|
|
Each capsule of Maxna contains 500 mg tranexamic acid.
Each 5 ml ampoule of Maxna contains 500 mg or 1gm of of tranexamic acid.
|
| |
|
Description:
|
|
Maxna contains tranexamic acid,
an antifibrinolytic agent, used to treat or prevent haemorrhage in a
variety of bleeding disorders.
|
| |
|
Indications:
|
- Dysfunctional uterine bleeding (DUB)
- Menorrhagia
- Ante- & post-partum hemorrhages
|
| |
|
Dosage:
|
|
Capsules:
The usual adult dose of capsule is 500 mg three or four times daily depending on the severity of the condition.
Injection:
For patients unable to take oral medication, Maxna injection can be administered in a dose of 10 mg/kg bodyweight 3 to 4 times daily.
|
| |
|
Presentations:
|
- 500 mg caps 20’s,
- 500 mg Inj 10’s,
- 1 gm Inj 10’s,
|
|
|
